Calculators

401k Retirement Calculator Mortgage Calculator

New

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

ACADIA Pharmaceuticals (ACAD)

NASDAQ:ACAD

ACAD

ACADIA Pharmaceuticals

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

ACADIA Pharmaceuticals (ACAD) Income Statement

2,190 Followers

ACADIA Pharmaceuticals Income Statement

Last quarter (Q1 2024), ACADIA Pharmaceuticals's total revenue was $205.83M, an increase of 73.75% from the same quarter last year. In Q1, ACADIA Pharmaceuticals's net income was $16.55M. See ACADIA Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 813.81M	$ 726.44M	$ 517.24M	$ 484.14M	$ 441.75M	$ 339.08M
Cost of Revenue	$ 62.92M	$ 41.64M	$ 10.17M	$ 19.14M	$ 20.55M	$ 19.60M
Gross Profit	$ 750.88M	$ 684.80M	$ 507.07M	$ 465.00M	$ 421.20M	$ 319.48M
Operating Expense	$ 755.47M	$ 758.18M	$ 730.66M	$ 635.44M	$ 707.79M	$ 566.02M
Operating Income	$ -4.58M	$ -73.38M	$ -223.60M	$ -170.44M	$ -286.59M	$ -246.54M
Net Non Operating Interest Income Expense	$ 18.94M	$ 17.23M	$ 6.61M	$ 591.00K	$ 6.61M	$ 11.16M
Other Income Expense	$ -550.00K	$ -5.11M	$ -3.54M	$ -2.33M	$ -997.00K	$ 997.00K
Pretax Income	$ 14.86M	$ -51.04M	$ -213.44M	$ -167.52M	$ -280.97M	$ -234.38M
Tax Provision	$ 16.51M	$ 10.25M	$ 2.53M	$ 351.00K	$ 611.00K	$ 876.00K
Earnings From Equity Interest Net Of Tax	$ -51.04M	$ -51.04M	$ -213.44M	$ -167.52M	-	-
Net Income Common Stockholders	$ -1.71M	$ -61.29M	$ -215.97M	$ -167.87M	$ -281.58M	$ -235.26M
Basic EPS	$ >-0.01	$ -0.37	$ -1.34	$ -1.05	$ -1.79	$ -1.60
Diluted EPS	$ >-0.01	$ -0.37	$ -1.34	$ -1.05	$ -1.79	$ -1.60
Basic Average Shares	$ 3.19M	$ 163.82K	$ 161.68K	$ 160.49K	$ 157.33M	$ 147.20M
Diluted Average Shares	$ 5.02M	$ 163.82K	$ 161.68K	$ 160.49K	$ 157.33M	$ 147.20M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 818.39M	$ 799.82M	$ 740.83M	$ 654.58M	$ 728.34M	$ 585.62M
Net Income From Continuing And Discontinued Operation	$ -1.71M	$ -61.29M	$ -215.97M	$ -167.87M	$ -281.58M	$ -235.26M
Normalized Income	$ 25.77M	-	-	-	$ -281.58M	$ -235.26M
Interest Expense	-	-	-	-	-	-
EBIT	$ 10.15M	$ -73.38M	$ -213.44M	$ -167.52M	$ -286.59M	$ -246.54M
EBITDA	$ 15.53M	$ -67.83M	$ -214.18M	$ -161.81M	$ -283.65M	$ -243.78M

Currency in USD

ACADIA Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing